EXAS vs SNX · rev $2.76B vs P/E 16, rev $19.57B
EXACT Sciences Corporation (EXAS) versus Synnex Corporation (SNX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Synnex Corporation (SNX) is a electronics & computer distribution company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SNX revenue for 2026-05-31 was $19.57B. Net income was $334.1M. Revenue was up 14.1% from 2026-02-28 to 2026-05-31. SNX currently screens at market cap $11.13B and trailing P/E 15.9.
EXAS currently screens at market cap $20.03B. SNX currently screens at market cap $11.13B and trailing P/E 15.9.
Not investment advice. Open the EXAS and SNX stock pages for the full models.
Not investment advice.